report banner

News in English

PostNews: Press Release

PHI Is Opening A New Development Office In The US

As a result of the newly created alliance for advancing cell-based biomanufacturing which was recently communicated, PHI is taking the next step in its investment into regenerative medicine by opening an office in the Innovation Quarter in Winston-Salem.
Learn more …
PostNews
PHI part of new regenerative medicine alliance

BioStock: PHI part of new regenerative medicine alliance

BioStock contacted Product Manager Lisa Lindström to learn more about PHI’s newly formed technology development alliance for regenerative medicine and what excites her about the future.
Learn more …
PostNews: Press Release
Cell culture quality control at a leading contract manufacturer of cell therapies.

PHI, SAS, QIAGEN and BioSpherix form Alliance to Advance Cell-based Biomanufacturing

In association with the Wake Forest Institute for Regenerative Medicine, PHI, BioSpherix, analytics leader SAS and QIAGEN have created a technology development alliance to create the AI-based process control tools needed for automated biomanufacturing.
Learn more …
PostNews
Biostock-regenerative-medicine-phi

BioStock: PHI expands market potential with regenerative medicine opportunity

BioStock contacted CFO Patrik Eschricht to find out more about PHI’s visions regarding regenerative medicine, cell-based therapies and automatization of biomanufacturing.
Learn more …
PostNews: Interim Report
Technician checking stem cell culture

Interim Report 1 2022/23

Despite a summer-sluggish period ending in July, sales were just one unit away from surpassing our best quarter ever; the same period last year.
Learn more …
PostNews: Press Release
PHIs-CEO-Peter-Egelberg-at-the-RegeneratOR-Test-Bed-at-WFIRM_web

Wake Forest Institute for Regenerative Medicine Welcomes PHI

PHI visits the WFIRM to finalize an agreement concerning the automation of advanced quality control in large-scale biomanufacturing of regenerative therapies.
Learn more …
191011121333